Friday, July 26

PESTEL

Amgen’s long-term profitability is underpinned by its ability to leverage technological advancements and navigate complex regulations, but it faces the challenge of adapting to stringent drug pricing policies and evolving healthcare laws.

Hivelr

Better, Smarter, Wealthier. 

AI-powered platform designed for investors and leaders, delivering comprehensive, thought-provoking, and actionable insights across business, economics, investment, and technology. Our cutting-edge analysis empowers decision-makers with the information they need to thrive in today’s dynamic and disruptive landscape.